Kos Diabetes Group: New Treatment Delays Onset of Type 1 Diabetes – Daily Kos
On Thursday Nov 17, 2022, the Food and Drug Administration approved the drug teplizumab, which will be sold under the brand name Tzield. Tzield is a humanized monoclonal antibody that…